ELTROMBOPAG

Generic: ELTROMBOPAG

XLCare Pharmaceuticals Inc.Manufacturer
ORALRoute
ELTROMBOPAG OLAMINEActive Substance
2025-01-17Original Approval

ELTROMBOPAG is FDA application ANDA206788, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
PLATELET COUNT DECREASED
1,754 reports
2
DRUG INEFFECTIVE
919 reports
3
OFF LABEL USE
786 reports
4
DEATH
604 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
445 reports
6
PLATELET COUNT INCREASED
422 reports
7
THROMBOCYTOPENIA
412 reports
8
HEADACHE
399 reports
9
FATIGUE
371 reports
10
HAEMOGLOBIN DECREASED
344 reports